Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeMD, Inc.LFMD · Entity 6521 | Chief Accounting Officer | August 22, 2025 | August 26, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeMD, Inc.
Report date August 22, 2025 · Filed August 26, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 227,500 |
Reported balance
After 2025-08-22 transaction · row 1
1 source rowRow 1 · 2025-08-22 · Grant · Acquired 20,000 · Balance 227,500 F1: Represents grant of performance stock which vested on August 22, 2025 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of performance stock which vested on August 22, 2025
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 22, 2025 Filed Aug 26, 2025 22:20 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000917 · form4.xml · nonDerivative · entry 1 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,500 F1 · price: Represents grant of performance stock which vested on August 22, 2025 Read SEC document |
| March 31, 2025 Filed Apr 3, 2025 18:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000369 · form4.xml · nonDerivative · entry 6 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,500 F6 · price: The restricted stock units vest in full on January 1, 2027. Read SEC document |
| March 31, 2025 Filed Apr 3, 2025 18:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000369 · form4.xml · nonDerivative · entry 5 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 F5 · price: Represents grant of performance stock which vested on March 31, 2025. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:23 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000284 · form4.xml · nonDerivative · entry 2 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,125 F2 · price: Represents grant of performance stock which vested on March 7, 2025. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 22:23 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000284 · form4.xml · nonDerivative · entry 1 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,125 F1 · price: Represents grant of restricted shares which vests on January 1, 2026. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 17:30 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-24-000011 · primary_doc.xml · nonDerivative · entry 1 STAN MARIA E. · CIK 0001908678 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,125 F1 · price: Performance shares vested on March 21, 2024. Read SEC document |
| November 07, 2023 Filed Apr 3, 2025 18:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000369 · form4.xml · nonDerivative · entry 4 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,500 F4 · price: Restricted stock units vested on January 1, 2025. Read SEC document |
| November 07, 2023 Filed Apr 3, 2025 18:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000369 · form4.xml · nonDerivative · entry 3 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,500 F3 · price: Restricted stock units vested on January 1, 2024. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 19:38 UTC | LifeMD, Inc. LFMD · Entity 6521 | Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-22-000013 · primary_doc.xml · derivative · entry 3 STAN MARIA E. · CIK 0001908678 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: 5,000 RSUs vested on February 4, 2022. Of the remaining RSUs, 5,000 vest on February 4, 2023 and 5,000 RSUs vest on February 4, 2024. F1 · derivative.expiration_date: 5,000 RSUs vested on February 4, 2022. Of the remaining RSUs, 5,000 vest on February 4, 2023 and 5,000 RSUs vest on February 4, 2024. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 19:38 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantRestricted Stock Unit · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001362118-22-000013 · primary_doc.xml · derivative · entry 2 STAN MARIA E. · CIK 0001908678 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F1 · derivative.exercise_date: 5,000 RSUs vested on February 4, 2022. Of the remaining RSUs, 5,000 vest on February 4, 2023 and 5,000 RSUs vest on February 4, 2024. F1 · derivative.expiration_date: 5,000 RSUs vested on February 4, 2022. Of the remaining RSUs, 5,000 vest on February 4, 2023 and 5,000 RSUs vest on February 4, 2024. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 19:38 UTC | LifeMD, Inc. LFMD · Entity 6521 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-22-000013 · primary_doc.xml · nonDerivative · entry 1 STAN MARIA E. · CIK 0001908678 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2022 Filed Apr 3, 2025 18:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000369 · form4.xml · nonDerivative · entry 2 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,500 F2 · price: 5,000 restricted stock units vested on each February 4, 2023 and February 4, 2024. Read SEC document |
| July 15, 2021 Filed Apr 3, 2025 18:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000369 · form4.xml · nonDerivative · entry 1 STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 F1 · price: 3,125 restricted stock units vested on each July 15, 2022, July 15, 2023 and July 15, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.